Cel Sci (CVM) Debt Ratio (2010 - 2018)

Cel Sci (CVM) posted Debt Ratio of 0.05 for Q1 2018, up 29.2% sequentially from 0.04 in Q4 2017.

Cel Sci (CVM) Debt Ratio (2010 - 2018) Analysis & Trends

Cel Sci has reported Debt Ratio for 7 years, with the latest figure at 0.05 in Q1 2018.

Quarterly Debt Ratio changed N/A year-over-year to 0.05 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was 0.05 (changed N/A YoY) and the FY2017 annual result came in at 0.04, changed N/A from the prior year.
Debt Ratio advanced to 0.05 in Q1 2018 per CVM's latest filing, from 0.04 in the prior quarter.
Over five years, Debt Ratio peaked at 0.05 in Q1 2018 and troughed at 0.01 in Q2 2017.
A 3-year average of 0.04 and a median of 0.04 in 2017 frame the typical range for Debt Ratio.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.05 Bn	131.20 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.99 Bn	78.00 Bn	3.93 Bn	0.05
3	Argenx Se	65.49 Bn	60.31 Bn	1.37 Bn	-
4	Moderna	56.79 Bn	51.65 Bn	52.00 Mn	0.05
5	BeOne Medicines	42.14 Bn	37.05 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.27 Bn	992.69 Mn	-
7	BioNTech SE	27.71 Bn	9.32 Bn	668.28 Mn	0.03
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.35 Bn	26.51 Bn	-	0.47
10	Cel Sci	2.16 Mn	-4.37 Mn	-	-

Download Data